What is Virtual Incision?
Headquartered in Lincoln, Nebraska, Virtual Incision is a pioneer in the surgical robotics industry, dedicated to reimagining how procedures are performed. The company focuses on developing innovative, miniaturized robotic platforms that offer unprecedented mobility, flexibility, and accessibility. By prioritizing simple, effective design, Virtual Incision aims to democratize access to minimally invasive surgical options, ultimately improving patient outcomes and streamlining hospital workflows. Their market position is defined by a unique approach to robotic-assisted surgery that challenges the status quo of large, cumbersome systems.
How much funding has Virtual Incision raised?
Virtual Incision has raised a total of $114.9M across 7 funding rounds:
Private Equity
$1.8M
Series A
$3.9M
Private Equity
$1.8M
Private Equity
$11.2M
Series B
$20M
Debt
$150K
Series C
$76M
Private Equity (2010): $1.8M with participation from PrairieGold Venture Partners and Bluestem Capital
Series A (2010): $3.9M led by Bluestem Capital and PrairieGold Venture Partners
Private Equity (2015): $1.8M supported by Bluestem Capital and PrairieGold Venture Partners
Private Equity (2015): $11.2M featuring PrairieGold Venture Partners and Bluestem Capital
Series B (2020): $20M backed by PrairieGold Venture Partners, Bluestem Capital, and Genesis Innovation Group
Debt (2020): $150K with participation from PPP
Series C (2023): $76M led by Endeavour Vision, Baird Capital, and Bluestem Capital
Key Investors in Virtual Incision
Endeavour Vision
Endeavour Vision is a leading investment advisory firm specializing in transformative healthcare technologies, particularly in medical devices and digital health.
Baird Capital
Baird Capital is a private equity and venture capital firm that invests in founder-led B2B tech and services companies globally, providing operational support to foster growth.
Bluestem Capital
Bluestem Capital is a venture capital firm based in Sioux Falls, South Dakota, focusing on private equity investments in the Midwest to support and grow companies within its portfolio.
What's next for Virtual Incision?
With the recent influx of capital, Virtual Incision is poised to transition into a critical scaling phase. The strategic focus will likely center on regulatory milestones, clinical validation, and the commercialization of its flagship robotic platforms. As the company moves beyond its initial development stages, the emphasis will shift toward establishing a broader clinical presence and refining its supply chain to meet anticipated demand. Investors are closely monitoring the firm's ability to integrate these technological advancements into standard surgical practices, which could redefine the competitive landscape of the medical device sector.
See full Virtual Incision company page
